It was a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
A webinar held by the Kaiser Family Foundation (KFF) in April shared highlights from the 2020 Women’s Health Survey, followed by a panel discussion on its implications in several areas. This article captures the discussion portion of the webinar.
“GO MOMs will set the foundation for determining future approaches to the screening, diagnosis, and eventually, the treatment of elevated blood glucose during pregnancy,” said NIDDK program director Barbara Linder, MD, PHD, the project scientist for the study.
Join Senior Editor Angie DeRosa as Sarah J. Kilpatrick, MD, PhD; and Christian M. Pettker, MD debate noun use. Should ob/gyns use the terms, "pregnant women" or "pregnant persons?" Let us know what you think via Twitter @ContempOBGYN.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More